Quell Therapeutics has raised £35M in Series A funding from investors that include Syncona Partners LLP and UCL Technology Fund. Quell Therapeutics was founded in 2019.
Say goodbye to recruiter spam
No more recruiter spam! Eliminate wasted time of managing communications with irrelevant job positions by only getting matched with relevant jobs based on his career goals. Indeed Prime matches you with top companies which align with your career goals, technical skill set, and location preferences.